Haemonetics Corporation (HAE)
Return on equity (ROE)
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 117,558 | 126,574 | 128,277 | 136,566 | 115,401 | 95,759 | 86,047 | 67,706 | 43,375 | 22,593 | 31,243 | 64,488 | 79,469 | 108,134 | 106,147 | 95,532 | 76,526 | 79,737 | 41,363 | 22,603 |
Total stockholders’ equity | US$ in thousands | 959,959 | 943,319 | 893,660 | 864,616 | 817,997 | 775,979 | 729,009 | 770,423 | 749,424 | 730,775 | 698,549 | 677,080 | 731,670 | 719,152 | 667,923 | 608,569 | 587,109 | 574,580 | 583,754 | 590,966 |
ROE | 12.25% | 13.42% | 14.35% | 15.79% | 14.11% | 12.34% | 11.80% | 8.79% | 5.79% | 3.09% | 4.47% | 9.52% | 10.86% | 15.04% | 15.89% | 15.70% | 13.03% | 13.88% | 7.09% | 3.82% |
March 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $117,558K ÷ $959,959K
= 12.25%
Haemonetics Corporation's return on equity (ROE) has shown fluctuations over the past few quarters. The ROE has generally been trending upwards from the end of 2020 to the middle of 2023, reaching a peak of 15.89% in September 2020. However, there was a slight decrease in ROE in the most recent quarter, dropping to 12.25%.
Overall, the ROE for Haemonetics Corporation has been relatively healthy, consistently above 10% in most periods. This indicates that the company has been generating a favorable return on shareholders' equity. It is essential to monitor these fluctuations in ROE to assess the company's efficiency in utilizing its equity to generate profits for its shareholders.
Peer comparison
Mar 31, 2024